Steven Whitebread
86 works · 7,981 citations · h-index 40
Top works
- Preliminary biochemical characterization of two angiotensin II receptor subtypes
- A receptor subtype involved in neuropeptide-Y-induced food intake
- Three new epoxy-spirolactone derivatives: characterization in vivo and in vitro.
- Large-scale prediction and testing of drug activity on side-effect targets
- Analysis of Pharmacology Data and the Prediction of Adverse Drug Reactions and Off‐Target Effects from Chemical Structure
- Reducing safety-related drug attrition: the use of in vitro pharmacological profiling
- Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1‐receptor subtype
- Keynote review: In vitro safety pharmacology profiling: an essential tool for successful drug development
- Modeling Promiscuity Based on in vitro Safety Pharmacology Profiling Data
- Mapping Adverse Drug Reactions in Chemical Space
- Angiotensin II AT2 receptors do not interact with guanine nucleotide binding proteins
- Food intake in free-feeding and energy-deprived lean rats is mediated by the neuropeptide Y5 receptor.
- Biochemical Characterization of Two Angiotensin II Receptor Subtypes in the Rat
- Inhibition of Food Intake by Neuropeptide Y Y5 Receptor Antisense Oligodeoxynucleotides
- Valsartan, a potent, orally active angiotensin II antagonist developed from the structurally new amino acid series
- Gaining Insight into Off-Target Mediated Effects of Drug Candidates with a Comprehensive Systems Chemical Biology Analysis
- Renal actions of the selective angiotensin AT2 receptor ligands CGP 42112B and PD 123319 in the sodium-depleted rat
- Ghrelin Acts on Leptin‐Responsive Neurones in the Rat Arcuate Nucleus
- Binding of valsartan to mammalian angiotensin AT1 receptors
- Down-regulation of protein kinase C potentiates angiotensin II-stimulated polyphosphoinositide hydrolysis in vascular smooth-muscle cells